HDL

Diabetes

June 2, 2021

SGLT2 inhibitors improve biomarkers indicative of CVD risk in diabetes patients: Study
Heart Disease

January 23, 2021

NIH grant bolsters research on heart disease, cholesterol | VUMC Reporter | Vanderbilt University